Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dain, Moon"'
Publikováno v:
Journal of the Korean Society of Hazard Mitigation. 23:81-90
Recently, studies have been actively conducted for increasing the length of bridges by connecting steel composite and concrete girders. This study proposes a prestressed steel composite concrete girder and analyzes the composite behavior of the propo
Autor:
Kun-Joo Lee student, Nara Tae, Yeon-Woo Kang, Dain Moon, Youngsik Oh, Ji-Hae Kim, Minji Lee, Ha Won Song, Sun Shim Choi, Donghoon Choi, Dae Hee Kim, Seung-Woo Lee
Publikováno v:
Regular and Young Investigator Award Abstracts.
Publikováno v:
Immune Network. 22
In the era of immunotherapeutic control of cancers, many advances in biotechnology, especially in Ab engineering, have provided multiple new candidates as therapeutic immuno-oncology modalities. Bispecific Abs (BsAbs) that recognize 2 different antig
Publikováno v:
Vaccines
Vaccines, Vol 9, Iss 724, p 724 (2021)
Vaccines, Vol 9, Iss 724, p 724 (2021)
Following the clinical success of cancer immunotherapies such as immune checkpoint inhibitors blocking B7/CTLA-4 or PD-1/PD-L1 signaling and ongoing numerous combination therapies in the clinic,3 bispecific antibodies (BsAbs) are now emerging as a gr
Autor:
Seung-Woo Lee, Shinai Lee, Wonjun Son, Eunyoung Park, Yunji Park, Park Kyeongsu, Sora Kim, Ji-Hae Kim, Yeon-Woo Kang, Yangsoon Lee, Jonghwa Won, Han Wook Park, Yong-Gyu Son, Jung Uijung, Young-Min Kim, Dain Moon, Gihoon You, Hyekang Kim, Eom Jaehyun, Chung Hyejin, Jaeho Jung
Publikováno v:
Science Advances. 7
Cancer immunotherapy with 4-1BB agonists has limited further clinical development because of dose-limiting toxicity. Here, we developed a bispecific antibody (bsAb; B7-H3×4-1BB), targeting human B7-H3 (hB7-H3) and mouse or human 4-1BB, to restrict t
Publikováno v:
Immune Network
The emergence of a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has become a significant health concern worldwide. Undoubtedly, a better understanding of the innate and adaptive immune responses against SARS-CoV-2 and its
Autor:
Yunji Park, Byung Ha Lee, Ji-Hae Kim, Seung-Woo Lee, Se Hwan Yang, Yeon-Woo Kang, Dae Hee Kim, Kun-Joo Lee, Donghoon Choi, S.S. Park, Dain Moon, Nara Tae
Publikováno v:
Regular and young investigator award abstracts.
Background rhIL-7-hyFc is a hybrid Fc-fused recombinant human interleukin-7 (NT-I7; efineptakin-alfa) with enhanced bioactivity. In a previous study, we found that a systemic administration of rhIL-7-hyFc induced antitumor effect by increasing CD8+ T
Autor:
Gihoon, You, Yangsoon, Lee, Yeon-Woo, Kang, Han Wook, Park, Kyeongsu, Park, Hyekang, Kim, Young-Min, Kim, Sora, Kim, Ji-Hae, Kim, Dain, Moon, Hyejin, Chung, Wonjun, Son, Ui-Jung, Jung, Eunyoung, Park, Shinai, Lee, Yong-Gyu, Son, Jaehyun, Eom, Jonghwa, Won, Yunji, Park, Jaeho, Jung, Seung-Woo, Lee
Publikováno v:
Science Advances
Tumor-targeted T cell costimulatory antibody augments antitumor immunity by enhancing tumor-killing T cells within the tumor.
Cancer immunotherapy with 4-1BB agonists has limited further clinical development because of dose-limiting toxicity. He
Cancer immunotherapy with 4-1BB agonists has limited further clinical development because of dose-limiting toxicity. He